| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/20/2013 | EP2558463A1 Fused derivatives as i3 inhibitors |
| 02/20/2013 | EP2558462A1 Pyridyl-vinyl pyrazoloquinolines as par1 inhibitors |
| 02/20/2013 | EP2558459A1 Phthalazin-(2h)-one inhibitors of kinases |
| 02/20/2013 | EP2558457A1 Arylethynyl derivatives |
| 02/20/2013 | EP2558456A1 Dithiin derivatives as fungicides |
| 02/20/2013 | EP2558454A2 Androgen induced oxidative stress inhibitors |
| 02/20/2013 | EP2558452A2 Oxazole and thiazole compounds as ksp inhibitors |
| 02/20/2013 | EP2558450A1 Triazole compounds as ksp inhibitors |
| 02/20/2013 | EP2558449A1 Novel 3,3-dimethyl tetrahydroquinoline derivatives |
| 02/20/2013 | EP2558447A1 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators |
| 02/20/2013 | EP2558446A1 Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins |
| 02/20/2013 | EP2558440A1 Process for the production of polymorph form i of agomelatine |
| 02/20/2013 | EP2558437A2 Methods for producing viloxazine salts and novel polymorphs thereof |
| 02/20/2013 | EP2558436A1 Stabilised polyphenol derivatives, process for their manufacture, and uses thereof |
| 02/20/2013 | EP2558435A1 Crystalline ingenol mebutate |
| 02/20/2013 | EP2558126A2 Substituted 2,3-dihydroimidazo[1,2-c]quinazoline-containing combinations |
| 02/20/2013 | EP2558124A1 Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
| 02/20/2013 | EP2558122A1 Combination treatment with vegf-c antagonists |
| 02/20/2013 | EP2558109A2 Method for treating solid tumors |
| 02/20/2013 | EP2558106A1 Methods and compositions for improving implant osseointegration |
| 02/20/2013 | EP2558105A2 Method of treating obesity using antioxidant inflammation modulators |
| 02/20/2013 | EP2558104A1 Method and ophthalmic composition for treating retinal disease |
| 02/20/2013 | EP2558103A1 Pharmaceutical composition for treating macular edema |
| 02/20/2013 | EP2558102A1 Synergistic interaction of at least one vitamin e component and tyrosinase inhibitors for dermatological applications |
| 02/20/2013 | EP2558101A1 Topical treatments for pain |
| 02/20/2013 | EP2558100A1 Compositions and methods for treating visual disorders |
| 02/20/2013 | EP2558099A2 Kinase inhibitors |
| 02/20/2013 | EP2558098A2 Treatment of endocrine resistant breast cancer |
| 02/20/2013 | EP2558097A1 Compound for treatment of respiratory condition or disease |
| 02/20/2013 | EP2558096A1 Combination of hypoxia-inducible factor-1 inhibitors and toll-like receptor-3 agonists for treating solid tumors |
| 02/20/2013 | EP2558095A1 Organic compound for use in the treatment of liver cancer |
| 02/20/2013 | EP2558094A1 Pyridone derivatives |
| 02/20/2013 | EP2558093A1 Prodrugs of an hiv reverse transcriptase inhibitor |
| 02/20/2013 | EP2558092A1 Combination comprising a cyclin dependent kinase 4 or cyclin dependent kinase (cdk4/6) inhibitor and an mtor inhibitor for treating cancer |
| 02/20/2013 | EP2558091A1 Combination of a macrocyclic inhibitor of hcv, a non-nucleoside and a nucleoside |
| 02/20/2013 | EP2558090A1 Radiation sensitiser compositions |
| 02/20/2013 | EP2558089A1 Statins for the prevention or treatment of drug addictions |
| 02/20/2013 | EP2558088A1 Polymer composition with phytochemical and dialysis membrane formed from the polymer composition |
| 02/20/2013 | EP2558087A1 AMIDO COMPOUNDS AS RORyt MODULATORS AND USES THEREOF |
| 02/20/2013 | EP2558086A1 Homeopathic medicament comprising phenacetin for the treatment of cancer |
| 02/20/2013 | EP2558085A2 Compositions and methods for the prevention and treatment of cancer |
| 02/20/2013 | EP2558084A2 Combination of vitamin k and nicotinamide |
| 02/20/2013 | EP2558083A1 Methods for providing enhanced resveratrol activity using 4-acetoxy-resveratrol |
| 02/20/2013 | EP2558082A1 Combination of organic compounds |
| 02/20/2013 | EP2558081A2 Intraocular pressure reduction with intracameral bimatoprost implants |
| 02/20/2013 | EP2558079A1 Ciprofloxacin dry syrup composition |
| 02/20/2013 | EP2558077A2 Oral pharmaceutical composition comprising fenofibric acid and an alkalifying agent |
| 02/20/2013 | EP2558073A1 Oral testosterone ester formulations and methods of treating testoterone deficiency comprising same |
| 02/20/2013 | EP2558071A2 Stable liquid oily ready-to-use formulations, preparation thereof and use thereof |
| 02/20/2013 | EP2558070A1 Acetaminophen composition |
| 02/20/2013 | EP2558069A1 Benzonapthyridine compositions and uses thereof |
| 02/20/2013 | EP2558065A1 Effervescent pharmaceutical compositions containing n-acetylcysteine |
| 02/20/2013 | EP2558064A2 Oral pharmaceutical dispersion compositions |
| 02/20/2013 | EP2558063A1 Very low-dosed solid oral dosage forms for hrt |
| 02/20/2013 | EP2557943A2 Oral veterinary pharmaceutical and nutraceutical compositions |
| 02/20/2013 | EP2557940A1 Animal feed additive having an antimicrobial and growth-promoting effect |
| 02/20/2013 | EP2557924A1 Dermal pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide and method of use |
| 02/20/2013 | EP2557923A1 Treatment of cancers having k-ras mutations |
| 02/20/2013 | EP2557921A1 Methods for treatment of sleep-related breathing disorders |
| 02/20/2013 | EP2557920A1 Methods for treating glucose metabolic disorders |
| 02/20/2013 | EP2557919A1 Stabilized statin formulations |
| 02/20/2013 | EP2557915A1 Compounds for prevention of cell injury |
| 02/20/2013 | EP1934212B1 9-azabicyclo [3 . 3 . 1]nonane derivatives as monoamine reuptake inhibitors |
| 02/20/2013 | EP1863472B1 Amino acid composition for improving glucose tolerance |
| 02/20/2013 | CN102939537A Yeast cell wall components and detection thereof |
| 02/20/2013 | CN102939292A Spirocyclic compounds and their use as therapeutic agents and diagnostic probes |
| 02/20/2013 | CN102939291A Phosphonates with reduced toxicity for treatment of viral infections |
| 02/20/2013 | CN102939290A 2,3 dihydro-1h-inden-1-yl- 2,7-diazaspiro [3.6] nonane derivatives and their use as antagonists or inverse agonists of the ghrelin receptor |
| 02/20/2013 | CN102939289A Substituted 5-fluoro-1h-pyrazolopyridines and use thereof |
| 02/20/2013 | CN102939287A 雌激素受体调节剂及其用途 Estrogen receptor modulators and their use |
| 02/20/2013 | CN102939286A Polysubstituted benzofurans and medicinal applications thereof |
| 02/20/2013 | CN102939284A Agent for treating hcv infection |
| 02/20/2013 | CN102939283A Indazole compounds useful as ketohexokinase inhibitors |
| 02/20/2013 | CN102939282A Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins |
| 02/20/2013 | CN102939281A Process for the preparation of glycopyrronium chloride |
| 02/20/2013 | CN102939280A Crystal form of glycopyrronium chloride |
| 02/20/2013 | CN102939279A Phenylthioacetate compounds, compositions and methods of use |
| 02/20/2013 | CN102939109A Combination of drugs with protein-binding prodrugs |
| 02/20/2013 | CN102939097A A novel synergistic pharmaceutical composition for topical applications |
| 02/20/2013 | CN102939092A Gamma-polyglutamic acid-based ocular irrigating solutions |
| 02/20/2013 | CN102939091A Pharmaceutical composition and use thereof in manufacturing medicaments for treating respiratory diseases |
| 02/20/2013 | CN102939090A Antagonists of mirna-29 expression and their use in the prevention and treatment of aortic aneurysms |
| 02/20/2013 | CN102939089A Method of treating obesity using antioxidant inflammation modulators |
| 02/20/2013 | CN102939088A Anti-viral compounds |
| 02/20/2013 | CN102939087A Novel indazole derivative or salt thereof, manufacturing intermediate therefor, antioxidant using same, and use for an indazole derivative or salt thereof |
| 02/20/2013 | CN102939086A Method of treating gastric cancer |
| 02/20/2013 | CN102939085A Intravaginal administration of misoprostol |
| 02/20/2013 | CN102939084A Acetyl-carnitine for use in a method for increasing neurogenesis in neural tissue |
| 02/20/2013 | CN102939083A Laminin-332 production accelerating composition |
| 02/20/2013 | CN102939082A Metal entrapped bioactive composites |
| 02/20/2013 | CN102939081A Therapeutic regimen and method for treating or ameliorating visual disorders associated with an endogenous retinoid deficiency |
| 02/20/2013 | CN102939080A Methods for providing enhanced resveratrol activity using 4-acetoxy-resveratrol |
| 02/20/2013 | CN102939077A Nanoemulsion composition containing vitamin k |
| 02/20/2013 | CN102939076A Chitosan |
| 02/20/2013 | CN102939057A Method for stimulating the reproductive capacity in a bull, and composition for stimulating the reproductive capacity in a bull |
| 02/20/2013 | CN102939009A Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 02/20/2013 | CN102939008A Methods of improving quality of sleep |
| 02/20/2013 | CN102939006A Heterocyclic sulfone mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| 02/20/2013 | CN102936337A Poly (gamma-propargyl-L-glutamate)-polyamino acid segmented copolymer, functional segmented copolymer and preparation method |
| 02/20/2013 | CN102936291A Method for preparing selenylation poly mannuronic acid and application of selenylation poly mannuronic acid |